Table 1.
Molecules and organisms encapsulated into electrospun nanofibers.
| Encapsulated molecules | Polymer/polymer blends | Reference |
|---|---|---|
| Antibiotics | ||
| Rifampin | PLLA | [81] |
| Doxorubicin hydrochloride | PLLA | [81] |
| Paclitaxil | PLLA | [81] |
| Tetracycline hydrochloride | PEVA | [60] |
| Mefoxin | PLGA/PEG-b-PLLA | [82] |
| Plasmid DNA | ||
| pCMVb encoding a β-Galactosidase | PLGA and PLA-PEG | [83] |
| Growth Factors | ||
| Human β-nerve growth factor (NGF) | PCLEEP | [54] |
| Human glialcell-derived neurotrophic factor (GDNF) | PCLEEP | [84] |
| Bone morfogenetic protein-2 (BMP-2) | PLGA-Hap | [85] |
| Antimicrobial compounds | ||
| Silver nanoparticles | Cellulose acetate | [72] |
| PCL/silver-loaded zirconium phosphate | [86] | |
| Proteins | ||
| BSA | PEO | [87] |
| Lysozyme | PCL/PEO | [53] |
| Lysozyme | PCL/PEG | [77] |
| Cytochrome C | PLLA/PLL | [61] |
| Bacteria | ||
| Eschericia coli | ||
| Staphylococcus albus | PVA | [88] |
| Micrococcus luteus | ||
| Eschericia coli | PEO | [89] |
| Lactobacillus plantarum | PEO | [90] |
| Bacteriophages | ||
| T7 | ||
| T4 | ||
| λ | PVA | [88] |
| M13 | PVP | [91] |
PLLA: poly (L-lactide); PEVA: poly-ethylene-co-vinyl acetate; PLGA: poly-lactate-co-glycolide; PEG: polyethylene glycol; PLGA/PEG-b-PLLA: poly-lactate-co-glycolide/polyethylene glycol-block-poly(L lactide); PCL: poly ε-caprolactone; PCLEEP: poly ε-caprolactone ethyl ethylene phosphate; Hap: Hydroxyapatite; PEO: polyethylene oxide; PDLA: poly(D,L-lactide); PLL: poly(L-lysine); PVA: poly(vinyl alcohol); PVP: polyvinylpyrrolidone.